Last Updated: November 9, 2026

TIGAN Drug Patent Profile

Name: TIGAN Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

When do Tigan patents expire, and what generic alternatives are available?

Tigan is a drug marketed by King Pharms Llc and Ph Health and is included in two NDAs.

The generic ingredient in TIGAN is trimethobenzamide hydrochloride. There is one drug master file entry for this compound. Eight suppliers are listed for this compound. Additional details are available on the trimethobenzamide hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Tigan

A generic version of TIGAN was approved as trimethobenzamide hydrochloride by LUPIN on August 20^th, 2003.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for TIGAN?
What are the global sales for TIGAN?
What is Average Wholesale Price for TIGAN?

Summary for TIGAN

US Patents:	0
Applicants:	2
NDAs:	2
Finished Product Suppliers / Packagers:	3
Raw Ingredient (Bulk) Api Vendors:	65
Patent Applications:	696
Drug Prices:	Drug price information for TIGAN
What excipients (inactive ingredients) are in TIGAN?	TIGAN excipients list
DailyMed Link:	TIGAN at DailyMed

Drug patent expirations by year for TIGAN

Pharmacology for TIGAN

Drug Class	Antiemetic
Physiological Effect	Emesis Suppression

US Patents and Regulatory Information for TIGAN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
King Pharms Llc	TIGAN	trimethobenzamide hydrochloride	CAPSULE;ORAL	017531-006	Dec 13, 2001		DISCN	Yes	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Ph Health	TIGAN	trimethobenzamide hydrochloride	INJECTABLE;INJECTION	017530-001	Approved Prior to Jan 1, 1982	AP	RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

DrugChatter Q&A for TIGAN

Tigan generic?
Tigan cost?

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.